
| Pair Name | Rosmarinic acid, Indoleamine 2,3-dioxygenase 1 | ||
| Phytochemical Name | Rosmarinic acid (PubChem CID: 5281792 ) | ||
| Anticancer drug Name | Indoleamine 2,3-dioxygenase 1 (PubChem CID: / ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Rosmarinic acid, Indoleamine 2,3-dioxygenase 1 | |||
| Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
| Biological Phenomena | Induction-->Immunomodulatory | |||
| Gene Regulation | Up-regulation | Expression | IFNG | hsa3458 |
| Up-regulation | Expression | IL2 | hsa3558 | |
| Down-regulation | Expression | TNF | hsa7124 | |
| Down-regulation | Expression | IL10 | hsa3586 | |
| In Vivo Model | The H22 cells were inoculated into the peritoneal cavity of the mice. After three passages in cell ascites, the ascites was extracted and diluted to the concentration of 1.5×10⁷/ml with normal saline. The H22 cell suspension (3×106 cell /mouse) was subcutaneously injected into the right side of the axillary of mice. | |||
| Result | The mechanism might be related to regulating immune response and immunocytokines, as well as alleviating immunosuppression induced by Tregs in the tumor immune microenvironment. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Effects of gene silencing of indoleamine 2,3-dioxygenase 1 combined with rosmarinic acid on tumor immune microenvironment in H22 tumor-bearing mice. Int Immunopharmacol. 2023 Jun;119:110193. doi: 10.1016/j.intimp.2023.110193. | Click |